RT Journal Article
T1 Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2)
A1 Rueda, A
A1 Giralt, J
A1 Mañós, M
A1 Lozano, A
A1 Sistiaga, A
A1 García-Miragall, E
A1 Cacicedo, J
A1 Esteban, F
A1 Scola, B
A1 Contreras, J
A1 Ruiz, A
A1 Carral, A
A1 González-Aniceto, G
A1 Pastor, M
A1 Herranz, J J
A1 Bernal, M
A1 Mesía, R
K1 Head and neck cancer
K1 Clinical guidelines
K1 Spanish multidisciplinary consensus
K1 Delphi methodology
K1 Carcinoma de células escamosas
K1 Terapia combinada
K1 Consenso
K1 Neoplasias de cabeza y cuello
K1 Humanos
K1 Calidad de vida
K1 Especialización
AB Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific multimodality therapy, up to half of the patients will develop recurrence. Treatment selection based on a multidisciplinary tumor board represents the cornerstone of head and neck cancer, as it is essential for achieving the best results, not only in terms of outcome, but also in terms of organ-function preservation and quality of life. Evidence-based international and national clinical practice guidelines for head and neck cancer not always provide answers in terms of decision-making that specialists have to deal with in their daily practice. This is the first Expert Consensus on the Multidisciplinary Approach for Head and Neck Squamous Cell Carcinoma (HNSCC) elaborated by the Spanish Society for Head and Neck Cancer and based on a Delphi methodology. It offers a number of specific recommendations based on the available evidence and the expertise of our specialists to facilitate decision-making of all health-care specialists involved.
PB Elsevier
SN 1368-8375
YR 2017
FD 2017-04-17
LK http://hdl.handle.net/10668/2725
UL http://hdl.handle.net/10668/2725
LA en
NO Rueda A, Giralt J, Mañós M, Lozano A, Sistiaga A, García-Miragall E,  et al. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2). Oral Oncol. (2017); pii: S1368-8375(17)30087-8.
DS RISalud
RD Apr 4, 2025